{
    "organizations": [],
    "uuid": "84ce3096fa25c0419840b2c7097137eb2e3125b0",
    "author": "",
    "url": "https://www.reuters.com/article/brief-leap-therapeutics-provides-dkn-01/brief-leap-therapeutics-provides-dkn-01-program-update-idUSASC09SBF",
    "ord_in_thread": 0,
    "title": "BRIEF-Leap Therapeutics Provides Dkn-01 Program Update",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 14, 2018 / 9:04 PM / Updated 9 minutes ago BRIEF-Leap Therapeutics Provides Dkn-01 Program Update Reuters Staff March 14 (Reuters) - Leap Therapeutics Inc: * LEAP THERAPEUTICS PROVIDES DKN-01 PROGRAM UPDATE AND ANNOUNCES SCIENTIFIC PRESENTATIONS AT AACR ANNUAL MEETING * LEAP THERAPEUTICS INC - FIRST PATIENT HAS BEEN ENROLLED IN STUDY EVALUATING DKN-01 IN PATIENTS WITH GYNECOLOGICAL CANCERS Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)",
    "published": "2018-03-14T23:03:00.000+02:00",
    "crawled": "2018-03-14T23:19:46.018+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "updated",
        "minute",
        "ago",
        "therapeutic",
        "provides",
        "program",
        "update",
        "reuters",
        "staff",
        "march",
        "reuters",
        "leap",
        "therapeutic",
        "inc",
        "leap",
        "therapeutic",
        "provides",
        "program",
        "update",
        "announces",
        "scientific",
        "presentation",
        "aacr",
        "annual",
        "meeting",
        "leap",
        "therapeutic",
        "inc",
        "first",
        "patient",
        "enrolled",
        "study",
        "evaluating",
        "patient",
        "gynecological",
        "cancer",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}